Eastern Maine Medical Center

Eastern Maine Medical Center was paid $159.20M by Medicaid between Jan 2018 and Dec 2024, across 888 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 21% of everything it billed.

33Billing provider infoEASTERN MAINE MEDICAL CENTER
BANGOR, ME 04401

33aNPI1790789147assigned 06/13/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$159.20M

24GClaims3,344,045

24DCodes billed888

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Maine

Rank by total paid#2 of 33

Median peer was paid$4.34M

This provider vs. median37×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	442,841	$18.01M
2019	480,596	$20.89M
2020	437,826	$20.58M
2021	555,126	$26.43M
2022	517,724	$24.87M
2023	490,926	$25.18M
2024incomplete	419,006	$23.25M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	21%	519,824	405,719	$34.16M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	10%	48,841	44,988	$16.39M
J9271	Injection, pembrolizumab, 1 mg	4.6%	1,733	1,169	$7.29M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	3.2%	40,663	38,721	$5.15M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.6%	113,315	106,133	$4.08M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.9%	32,610	31,729	$2.96M
J9299	Injection, nivolumab, 1 mg	1.8%	722	448	$2.86M
D7140	Extraction, erupted tooth or exposed root	1.6%	1,118	921	$2.55M
J0585	Injection, onabotulinumtoxina, 1 unit	1.5%	4,315	3,092	$2.43M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	1.5%	18,997	17,868	$2.37M
77386		1.5%	10,910	930	$2.36M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.4%	18,912	9,946	$2.25M

876 more codes

76819	Fetal biophysical profile; without non-stress testing	1.3%	38,507	$2.02M
J2505	Injection, pegfilgrastim, 6 mg	1.2%	1,030	$1.95M
78815	Positron emission tomography (PET) for limited area imaging	1.1%	3,491	$1.78M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.1%	1,043	$1.78M
99213	Doctor's office visit, returning patient (routine)	1.1%	60,960	$1.73M
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	1.0%	873	$1.65M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	5,415	$1.54M
90791	Psychiatric diagnostic evaluation	<1%	29,128	$1.51M
99215	Doctor's office visit, returning patient (complex)	<1%	25,149	$1.50M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	16,656	$1.48M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,085	$1.45M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	7,020	$1.42M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	15,768	$1.26M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	10,359	$1.16M
99233	Hospital visit by a doctor, follow-up day (complex)	<1%	31,714	$1.15M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,312	$1.10M
99232	Hospital visit by a doctor, follow-up day	<1%	42,738	$1.02M
D0150	Comprehensive oral evaluation - new or established patient	<1%	1,264	$971K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	9,244	$931K
90832	Psychotherapy session, about 30 minutes	<1%	15,486	$923K
77412		<1%	10,791	$911K
J0178	Injection, aflibercept, 1 mg	<1%	1,074	$880K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	3,116	$784K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,666	$781K
77334		<1%	2,477	$731K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	826	$728K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	12,263	$721K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	15,837	$720K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	3,708	$661K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	5,473	$656K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	4,948	$633K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	10,741	$630K
99204	Doctor's office visit, new patient (more involved)	<1%	9,495	$618K
71046	Radiologic examination, chest; 2 views	<1%	16,917	$613K
J9312	Injection, rituximab, 10 mg	<1%	204	$593K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	17,376	$562K
90792	Psychiatric diagnostic evaluation with medical services	<1%	8,507	$560K
67028	Intravitreal injection of a pharmacologic agent	<1%	8,275	$534K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	22,210	$508K
70450	Computed tomography, head or brain; without contrast material	<1%	7,351	$506K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	617	$482K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	21,529	$475K
G0008	Administration of influenza virus vaccine	<1%	18,442	$443K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,311	$432K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	9,089	$431K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	7,201	$429K
95911		<1%	2,858	$415K
96375	Therapeutic injection; each additional sequential IV push	<1%	16,157	$412K
J0897	Injection, denosumab, 1 mg	<1%	815	$406K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	4,915	$382K
77300		<1%	2,130	$367K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	4,472	$358K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	5,039	$357K
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	<1%	176	$356K
95708		<1%	1,116	$350K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	21,415	$349K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,132	$341K
96367		<1%	9,761	$335K
96361	Intravenous infusion, hydration; each additional hour	<1%	12,033	$319K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	8,033	$317K
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	<1%	8,326	$316K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	73,558	$312K
52000		<1%	1,831	$306K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	8,048	$302K
99223	Prolong inpt eval add15 m	<1%	4,402	$298K
77336		<1%	6,419	$297K
G0379	Direct admission of patient for hospital observation care	<1%	250	$291K
20610		<1%	2,850	$287K
99205	Prolong outpt/office vis	<1%	2,735	$284K
43235		<1%	862	$283K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	27,523	$282K
95811		<1%	716	$281K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	2,130	$278K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,720	$277K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	7,481	$270K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	4,246	$266K
95886		<1%	12,158	$263K
76830	Ultrasound, transvaginal	<1%	3,536	$261K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	4,254	$247K
96116		<1%	1,505	$244K
J1453	Injection, fosaprepitant, 1 mg	<1%	2,377	$240K
64642		<1%	1,472	$240K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	<1%	3,677	$233K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	4,809	$231K
74183		<1%	1,752	$224K
95819		<1%	1,354	$223K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	3,331	$222K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	5,606	$222K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	4,371	$215K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,536	$211K
95909		<1%	2,324	$209K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	652	$207K
92587		<1%	1,021	$206K
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	86	$203K
93454		<1%	230	$202K
72141		<1%	1,591	$202K
99203	Doctor's office visit, new patient (routine)	<1%	4,690	$201K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	3,772	$199K
96416		<1%	1,517	$196K
77301		<1%	419	$193K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	159	$186K
96158		<1%	3,993	$184K
71250		<1%	3,516	$184K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	2,946	$180K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	8,329	$175K
95812		<1%	1,050	$174K
90834	Psychotherapy session, about 45 minutes	<1%	3,018	$171K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,020	$171K
90837	Psychotherapy session, about an hour	<1%	2,333	$165K
93971		<1%	3,400	$161K
93924		<1%	2,479	$161K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	<1%	4,986	$159K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	834	$157K
J0185	Injection, aprepitant, 1 mg	<1%	1,219	$156K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	6,707	$155K
76770		<1%	2,554	$153K
96415		<1%	4,499	$149K
72197		<1%	450	$147K
95910		<1%	1,777	$142K
96132		<1%	1,158	$142K
31575		<1%	1,905	$141K
93296		<1%	11,754	$141K
73221		<1%	1,188	$139K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	405	$138K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	12,316	$137K
0002A		<1%	5,840	$137K
90473		<1%	3,106	$136K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,676	$136K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	7,081	$133K
36561		<1%	126	$132K
96130		<1%	3,225	$130K
96417		<1%	4,682	$129K
93970		<1%	1,432	$128K
0001A		<1%	6,093	$125K
97803		<1%	5,693	$123K
92557		<1%	2,140	$123K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	668	$120K
76801		<1%	1,542	$119K
J0475	Injection, baclofen, 10 mg	<1%	727	$115K
71045	Radiologic examination, chest; single view	<1%	5,104	$115K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	10,395	$115K
93880		<1%	2,159	$115K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	10,405	$114K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	460	$114K
77338		<1%	967	$114K
97161		<1%	2,730	$112K
77295		<1%	248	$111K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	27	$108K
90686		<1%	12,567	$108K
00170	Anesthesia for intraoral procedures, including biopsy	<1%	1,023	$107K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	58	$106K
58661		<1%	29	$104K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	113	$98K
94010		<1%	4,073	$94K
J2997	Injection, alteplase recombinant, 1 mg	<1%	883	$91K
93923		<1%	2,709	$91K
J2777	Injection, faricimab-svoa, 0.1 mg	<1%	166	$89K
64615		<1%	880	$88K
77290		<1%	721	$88K
99239	Hospital discharge day management, more than 30 minutes	<1%	2,133	$87K
43249		<1%	156	$85K
51705		<1%	1,320	$83K
94726		<1%	1,344	$82K
76536		<1%	1,456	$81K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	76	$81K
77066	Tomosynthesis, mammo	<1%	1,172	$79K
76642		<1%	2,383	$78K
99220		<1%	1,016	$77K
96101		<1%	763	$77K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	98	$74K
95700		<1%	590	$74K
62369		<1%	1,068	$74K
Q3014	Telehealth originating site facility fee	<1%	5,753	$74K
97162		<1%	2,226	$73K
93225		<1%	1,856	$72K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,933	$70K
95953		<1%	263	$70K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	654	$69K
96411		<1%	2,084	$69K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	48,130	$67K
93017		<1%	3,702	$67K
72100		<1%	3,299	$66K
93798		<1%	1,430	$66K
90677		<1%	1,431	$66K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	2,387	$65K
D2929		<1%	71	$65K
96131		<1%	3,173	$63K
97163		<1%	2,340	$63K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	14,423	$62K
84443	Thyroid stimulating hormone (TSH)	<1%	19,578	$61K
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)	<1%	1,525	$61K
92523		<1%	514	$59K
80053	Comprehensive metabolic panel	<1%	97,512	$59K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	8,309	$58K
64493		<1%	130	$58K
70491		<1%	441	$58K
99222	Initial hospital care, per day, moderate complexity	<1%	1,118	$54K
96152		<1%	649	$53K
99495		<1%	999	$53K
36593		<1%	431	$52K
93295		<1%	3,265	$52K
59025	Fetal non-stress test	<1%	421	$52K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	6,396	$51K
93312		<1%	482	$51K
52310		<1%	73	$51K
77080		<1%	1,218	$50K
72158		<1%	422	$49K
73564		<1%	4,966	$49K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	6,064	$49K
77065	Tomosynthesis, mammo	<1%	1,070	$48K
86900		<1%	4,773	$48K
93320		<1%	7,886	$48K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	105,873	$47K
74018		<1%	2,760	$46K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	<1%	14	$46K
92134		<1%	10,734	$46K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	152	$45K
36430		<1%	275	$45K
80061	Lipid panel	<1%	6,453	$45K
96118		<1%	337	$44K
80055		<1%	1,814	$44K
97802		<1%	1,476	$43K
90732		<1%	730	$41K
J2778	Injection, ranibizumab, 0.1 mg	<1%	210	$40K
94060		<1%	299	$38K
99238	Hospital discharge day management, 30 minutes or less	<1%	940	$37K
99406		<1%	2,598	$37K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	454	$37K
D1120	Dental cleaning, child	<1%	1,001	$37K
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	38	$36K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,511	$34K
97167		<1%	1,242	$34K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	705	$34K
73630		<1%	5,393	$32K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	1,863	$32K
51702		<1%	1,483	$32K
31231		<1%	363	$32K
97166		<1%	765	$31K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,973	$31K
00731		<1%	949	$30K
72050		<1%	927	$30K
D3240		<1%	103	$30K
96137		<1%	2,903	$30K
36415	Collection of venous blood by venipuncture	<1%	69,566	$30K
19083		<1%	53	$29K
70486		<1%	696	$29K
88184		<1%	728	$29K
76000		<1%	2,582	$29K
62323		<1%	123	$28K
64721		<1%	41	$28K
97035		<1%	5,281	$27K
73030		<1%	5,771	$27K
93294		<1%	3,132	$27K
87086	Culture, bacterial; quantitative colony count, urine	<1%	16,917	$26K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,203	$25K
73130		<1%	3,241	$25K
90670		<1%	3,507	$24K
84702		<1%	4,197	$23K
93226		<1%	1,905	$23K
87081		<1%	13,401	$23K
73610		<1%	4,704	$23K
95806		<1%	532	$23K
76820		<1%	3,463	$22K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	471	$22K
01922		<1%	554	$22K
96136		<1%	3,245	$22K
95251		<1%	1,081	$22K
77470		<1%	114	$21K
57454		<1%	107	$21K
99226		<1%	333	$20K
73502		<1%	3,505	$20K
92060		<1%	1,649	$20K
82728		<1%	9,977	$20K
99490	Ccm add 20min	<1%	657	$20K
83036	Hemoglobin; glycosylated (A1C)	<1%	18,493	$19K
D1206	Topical application of fluoride varnish	<1%	1,929	$19K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	83	$19K
73110		<1%	2,271	$19K
49083		<1%	67	$19K
74174		<1%	227	$19K
96150		<1%	177	$19K
58300		<1%	310	$19K
70544		<1%	149	$18K
64643		<1%	1,041	$18K
96138		<1%	1,241	$18K
D1351	Sealant - per tooth	<1%	183	$18K
95908		<1%	162	$18K
96409		<1%	242	$18K
93975		<1%	161	$18K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	53	$17K
51700		<1%	190	$17K
93271		<1%	328	$17K
93280		<1%	1,881	$17K
10060		<1%	132	$16K
98927		<1%	3,054	$16K
78306		<1%	115	$16K
87390		<1%	2,231	$16K
64483		<1%	52	$16K
58301		<1%	85	$16K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,423	$16K
73560		<1%	5,217	$16K
87631		<1%	6,287	$16K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	900	$16K
76870		<1%	395	$16K
95816		<1%	283	$15K
99188		<1%	1,050	$15K
99460		<1%	279	$15K
90651		<1%	1,359	$15K
93456		<1%	13	$14K
95874		<1%	2,834	$14K
92579		<1%	433	$14K
99496		<1%	247	$14K
72070		<1%	633	$14K
81025		<1%	15,398	$13K
99479	Subsequent intensive care, per day, very low birth weight infant	<1%	196	$13K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	26	$13K
99308	Subsequent nursing facility care, per day, straightforward	<1%	855	$13K
78431		<1%	28	$13K
99443		<1%	425	$13K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	159	$13K
96402		<1%	2,274	$13K
72082		<1%	440	$13K
G0433	Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening	<1%	1,364	$13K
90734		<1%	990	$12K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	705	$12K
93016		<1%	1,248	$12K
76825		<1%	24	$12K
88307		<1%	2,385	$12K
83550		<1%	9,130	$11K
J1750	Injection, iron dextran, 50 mg	<1%	82	$11K
29075		<1%	65	$11K
80305		<1%	17,372	$11K
70496		<1%	131	$11K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	385	$11K
93325		<1%	8,565	$11K
64644		<1%	63	$11K
83970		<1%	910	$11K
85027		<1%	12,072	$11K
72156		<1%	73	$11K
82950		<1%	2,435	$11K
0124A		<1%	836	$10K
73140		<1%	985	$10K
50435		<1%	27	$10K
82105		<1%	1,594	$10K
88342		<1%	4,346	$10K
86702		<1%	2,242	$10K
87205		<1%	12,448	$9K
83540		<1%	9,805	$9K
0004A		<1%	598	$9K
72146		<1%	115	$9K
86747		<1%	1,029	$9K
58100		<1%	87	$9K
72170		<1%	1,322	$9K
91010		<1%	32	$9K
90480		<1%	555	$9K
78264		<1%	44	$9K
82607		<1%	4,446	$9K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	325	$9K
67210		<1%	34	$8K
20553		<1%	58	$8K
0054A		<1%	536	$8K
99385		<1%	120	$8K
86701		<1%	2,245	$8K
20611		<1%	115	$8K
98926		<1%	1,519	$8K
86803		<1%	3,493	$8K
98928		<1%	1,672	$8K
27096		<1%	151	$8K
73521		<1%	408	$8K
73080		<1%	964	$8K
93018		<1%	1,249	$8K
74178		<1%	54	$8K
C9257	Injection, bevacizumab, 0.25 mg	<1%	2,561	$7K
83655		<1%	1,520	$7K
74230		<1%	112	$7K
87522	Neg quan hep c or qual rna	<1%	1,019	$7K
99221		<1%	293	$7K
73590		<1%	1,828	$7K
80502		<1%	288	$7K
73562		<1%	2,088	$7K
93000		<1%	504	$7K
95822		<1%	160	$7K
93926		<1%	148	$7K
80048	Basic metabolic panel (calcium, ionized)	<1%	15,742	$7K
87077		<1%	8,852	$6K
86850		<1%	5,176	$6K
84439		<1%	3,985	$6K
95913		<1%	40	$6K
92250		<1%	1,695	$6K
95951		<1%	51	$6K
99217		<1%	173	$6K
95938		<1%	62	$6K
90656		<1%	893	$6K
95941		<1%	40	$6K
G0009	Administration of pneumococcal vaccine	<1%	1,151	$6K
81003		<1%	28,288	$6K
88360		<1%	739	$6K
82677		<1%	319	$6K
G0378	Hospital observation service, per hour	<1%	17,710	$6K
72110		<1%	468	$5K
92610		<1%	181	$5K
97165		<1%	169	$5K
96156		<1%	109	$5K
93978		<1%	109	$5K
86592		<1%	1,672	$5K
93308		<1%	132	$5K
87536		<1%	1,212	$5K
73600		<1%	990	$5K
73090		<1%	1,341	$5K
99480	Subsequent intensive care, per day, low birth weight infant	<1%	66	$5K
86580		<1%	655	$5K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	12,635	$5K
86140		<1%	11,306	$5K
0071A		<1%	232	$5K
83735		<1%	30,231	$5K
74019		<1%	430	$5K
0072A		<1%	233	$5K
91320		<1%	230	$5K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	14,302	$5K
92511		<1%	66	$5K
93283		<1%	433	$5K
86480		<1%	289	$5K
75635		<1%	63	$5K
76885		<1%	82	$5K
99152		<1%	6,869	$4K
81001		<1%	14,880	$4K
94729		<1%	3,044	$4K
96133		<1%	1,229	$4K
93351		<1%	29	$4K
69209		<1%	978	$4K
93298		<1%	152	$4K
82948		<1%	28,377	$4K
96127		<1%	486	$4K
76827		<1%	355	$4K
99454		<1%	191	$4K
97116		<1%	403	$4K
86336		<1%	322	$4K
90662		<1%	1,810	$4K
90678		<1%	14	$4K
87186		<1%	5,084	$4K
76775		<1%	89	$4K
74221		<1%	37	$4K
90716		<1%	1,355	$4K
82746		<1%	1,965	$4K
96146		<1%	823	$3K
91322		<1%	106	$3K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	17	$3K
92235		<1%	42	$3K
87150		<1%	254	$3K
69210		<1%	1,635	$3K
82784		<1%	3,812	$3K
C8924	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study	<1%	30	$3K
36591		<1%	382	$3K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	14	$3K
51798		<1%	4,787	$3K
85610		<1%	21,441	$3K
92611		<1%	96	$3K
82570		<1%	2,504	$3K
82947		<1%	1,174	$3K
11982		<1%	12	$3K
84153		<1%	2,082	$3K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	9,904	$3K
73552		<1%	1,079	$3K
99381		<1%	43	$3K
87340		<1%	2,878	$3K
86706		<1%	2,531	$3K
85652		<1%	10,725	$3K
84156		<1%	2,546	$3K
72157		<1%	35	$3K
29065		<1%	14	$3K
96119		<1%	302	$2K
93284		<1%	247	$2K
93299		<1%	147	$2K
80076		<1%	1,338	$2K
84100		<1%	4,189	$2K
82977		<1%	2,280	$2K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	6,119	$2K
0052A		<1%	90	$2K
70498		<1%	159	$2K
86481		<1%	455	$2K
72040		<1%	859	$2K
76882		<1%	41	$2K
95115		<1%	227	$2K
76981		<1%	139	$2K
73700		<1%	40	$2K
98929		<1%	376	$2K
83516		<1%	1,373	$2K
0031A		<1%	112	$2K
86704		<1%	1,932	$2K
83690		<1%	10,250	$2K
73100		<1%	1,270	$2K
95117		<1%	133	$2K
70355		<1%	567	$2K
74220		<1%	25	$2K
11981		<1%	28	$2K
86038		<1%	1,220	$2K
96401		<1%	698	$2K
94070		<1%	12	$2K
96160		<1%	103	$2K
92002		<1%	44	$2K
92015	Determination of refractive state	<1%	2,560	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	4,865	$2K
96161		<1%	70	$2K
83993		<1%	178	$2K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	2,106	$2K
85730		<1%	2,166	$2K
71271		<1%	237	$2K
00811		<1%	42	$2K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	4,552	$2K
90746		<1%	32	$2K
85018		<1%	3,883	$2K
95937		<1%	30	$2K
84403		<1%	138	$1K
84600		<1%	253	$1K
84163		<1%	611	$1K
0051A		<1%	59	$1K
17110		<1%	38	$1K
62370		<1%	16	$1K
74160		<1%	12	$1K
82803		<1%	2,053	$1K
99397		<1%	122	$1K
83880		<1%	2,810	$1K
82565		<1%	3,602	$1K
95955		<1%	13	$1K
92083		<1%	220	$1K
86618		<1%	838	$1K
87070		<1%	2,781	$1K
92133		<1%	254	$1K
76821		<1%	202	$1K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	4,892	$1K
J2785	Injection, regadenoson, 0.1 mg	<1%	2,458	$1K
86360		<1%	847	$1K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	393	$1K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	788	$1K
85046		<1%	2,442	$1K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	10,625	$1K
82951		<1%	84	$1K
0081A		<1%	39	$1K
82043		<1%	1,706	$986.98
86359		<1%	935	$981.47
88304		<1%	1,541	$978.59
90710		<1%	693	$973.08
0011A		<1%	208	$968.88
92567		<1%	3,233	$957.18
84550		<1%	2,088	$945.86
77072		<1%	26	$917.35
83615		<1%	4,530	$915.28
82550		<1%	2,055	$914.65
0012A		<1%	110	$893.38
90620		<1%	313	$884.22
90681		<1%	649	$869.20
86160		<1%	322	$831.40
83001		<1%	141	$831.11
97597		<1%	21	$788.69
84460		<1%	809	$785.40
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	13	$783.55
J8501	Aprepitant, oral, 5 mg	<1%	2,330	$779.52
84165		<1%	1,522	$778.06
77280		<1%	15	$765.78
74420		<1%	393	$755.65
92285		<1%	426	$754.48
0053A		<1%	51	$731.41
87040		<1%	2,090	$693.66
84450		<1%	747	$692.23
72131		<1%	14	$680.82
82378		<1%	2,785	$668.01
0003A		<1%	49	$665.76
84484		<1%	11,813	$653.28
92526		<1%	15	$643.61
73070		<1%	650	$642.39
71101		<1%	94	$632.80
84146		<1%	63	$631.27
83520		<1%	339	$625.06
99497		<1%	29	$613.87
0082A		<1%	32	$612.32
81002		<1%	763	$590.97
01400		<1%	12	$578.44
99462		<1%	29	$568.75
83883		<1%	678	$563.84
80164		<1%	257	$556.56
93270		<1%	345	$553.41
86708		<1%	524	$548.84
88377		<1%	379	$539.11
81015		<1%	820	$531.21
82140		<1%	435	$513.90
G0010	Administration of hepatitis b vaccine	<1%	30	$507.50
C2617	Stent, non-coronary, temporary, without delivery system	<1%	508	$505.20
0074A		<1%	17	$498.34
93227		<1%	45	$496.41
99307		<1%	42	$494.59
77075		<1%	17	$491.67
90723		<1%	904	$489.92
84703		<1%	2,087	$482.49
90619		<1%	333	$472.35
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	500	$470.88
73060		<1%	141	$461.16
87075		<1%	2,534	$450.61
84466		<1%	122	$425.97
94690		<1%	26	$421.62
90744		<1%	808	$419.69
82248		<1%	363	$415.42
99356		<1%	12	$409.56
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	1,921	$401.19
83521		<1%	610	$398.57
83605		<1%	3,741	$395.73
G0316	Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes)	<1%	25	$394.99
99336		<1%	18	$390.98
88344		<1%	284	$390.47
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	204	$379.93
87427		<1%	65	$367.96
85049		<1%	1,253	$362.12
85014		<1%	1,987	$354.95
87329		<1%	67	$345.05
87328		<1%	67	$343.01
94664		<1%	1,455	$338.64
80178		<1%	277	$336.73
72081		<1%	70	$336.44
87902		<1%	28	$336.32
93282		<1%	12	$318.53
86364		<1%	248	$318.28
86901		<1%	4,989	$318.28
84112		<1%	107	$317.25
87493		<1%	42	$313.44
86300		<1%	653	$310.50
84520		<1%	830	$310.44
87046		<1%	70	$306.68
12001		<1%	146	$296.69
J1756	Injection, iron sucrose, 1 mg	<1%	2,427	$290.81
46600		<1%	79	$290.06
87045		<1%	69	$287.80
82670		<1%	31	$285.43
86430		<1%	456	$276.54
87641		<1%	49	$268.70
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	<1%	28	$268.26
90674		<1%	12	$264.55
86923		<1%	95	$252.48
93882		<1%	13	$249.59
C1769	Guide wire	<1%	6,084	$245.47
86225		<1%	179	$242.14
90653		<1%	387	$242.05
86200		<1%	319	$242.03
96159		<1%	727	$231.56
86304		<1%	174	$230.60
93293		<1%	13	$226.33
85379		<1%	2,209	$213.40
86235		<1%	140	$205.65
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	16	$200.70
86334		<1%	375	$198.45
99100		<1%	156	$186.78
29125		<1%	109	$184.46
82952		<1%	72	$175.48
86762		<1%	181	$173.47
87640		<1%	43	$169.38
80504		<1%	127	$167.98
96381		<1%	12	$159.36
J9196	Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg	<1%	25	$159.13
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	18	$158.95
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	<1%	2,602	$157.29
87468		<1%	103	$154.52
87484		<1%	103	$154.52
87469		<1%	103	$154.52
84132		<1%	2,140	$153.78
99457		<1%	45	$151.70
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	315	$135.14
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	859	$134.56
87517		<1%	39	$129.46
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	3,646	$124.10
J0736	Injection, clindamycin phosphate, 300 mg	<1%	65	$122.68
73565		<1%	770	$120.06
93228		<1%	12	$116.76
96120		<1%	113	$115.42
51741		<1%	87	$115.42
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	666	$110.86
90715		<1%	5,718	$103.67
87478		<1%	55	$98.24
86255		<1%	25	$96.94
80197		<1%	20	$96.58
80069		<1%	35	$95.31
88302		<1%	85	$94.71
87430		<1%	485	$93.48
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	26	$90.00
88173		<1%	319	$85.09
76376		<1%	1,188	$82.02
90680		<1%	1,659	$79.18
92504		<1%	13	$77.93
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,058	$76.65
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	14	$76.00
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	4,763	$75.84
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	100	$74.46
84155		<1%	346	$71.51
72080		<1%	42	$69.75
73000		<1%	30	$67.34
98925		<1%	17	$62.72
88142		<1%	134	$62.13
99173		<1%	32	$62.06
G2012	Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion	<1%	17	$61.13
82150		<1%	125	$56.04
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	285	$52.60
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,315	$51.51
99442		<1%	14	$50.05
77387		<1%	6,147	$48.68
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	9,609	$46.79
51701		<1%	62	$45.98
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	1,047	$43.05
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	1,343	$40.42
80051		<1%	26	$35.85
85384		<1%	95	$34.72
J1644	Injection, heparin sodium, per 1000 units	<1%	8,083	$31.82
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	423	$30.10
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	2,465	$29.90
87184		<1%	14	$29.73
89051		<1%	609	$29.00
J1170	Injection, hydromorphone, up to 4 mg	<1%	4,621	$27.42
86765		<1%	13	$26.19
94760		<1%	3,621	$19.98
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	119	$19.76
82657		<1%	55	$18.46
J2270	Injection, morphine sulfate, up to 10 mg	<1%	2,539	$18.32
86308		<1%	53	$17.57
83921		<1%	13	$16.83
82330		<1%	107	$16.42
87529		<1%	12	$15.91
J2060	Injection, lorazepam, 2 mg	<1%	2,526	$15.72
88185		<1%	709	$14.63
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	3,527	$13.62
86039		<1%	30	$11.16
87280		<1%	34	$10.94
77002		<1%	983	$8.85
86015		<1%	13	$8.07
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	451	$7.60
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	489	$7.60
84157		<1%	346	$7.53
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	2,148	$6.45
96368		<1%	2,362	$5.67
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,839	$5.67
J0640	Injection, leucovorin calcium, per 50 mg	<1%	1,097	$5.67
J9190	Injection, fluorouracil, 500 mg	<1%	1,498	$5.67
J1630	Injection, haloperidol, up to 5 mg	<1%	3,115	$5.24
96121		<1%	1,169	$5.00
85347		<1%	454	$4.28
82945		<1%	219	$3.93
84295		<1%	246	$3.00
88112		<1%	43	$2.39
96376		<1%	4,934	$1.67
99153	Mod sedat endo service >5yrs	0%	2,411	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	3,160	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	852	$0.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	0%	5,415	$0.00
G0269	Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug)	0%	219	$0.00
77001		0%	606	$0.00
96377		0%	766	$0.00
J2704	Injection, propofol, 10 mg	0%	2,857	$0.00
90474		0%	378	$0.00
36416		0%	199	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	178	$0.00
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	5,452	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	262	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	1,989	$0.00
J9045	Injection, carboplatin, 50 mg	0%	1,761	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	1,149	$0.00
90697		0%	634	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	637	$0.00
99439		0%	494	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	171	$0.00
90696		0%	887	$0.00
91301		0%	428	$0.00
96139		0%	1,250	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	2,021	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	120	$0.00
88341		0%	1,907	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	144	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	609	$0.00
J1815	Injection, insulin, per 5 units	0%	883	$0.00
90698		0%	1,508	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	117	$0.00
88300		0%	252	$0.00
91315		0%	30	$0.00
91305		0%	637	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	274	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	31	$0.00
C1893	Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away	0%	127	$0.00
A9555	Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries	0%	28	$0.00
V2632	Posterior chamber intraocular lens	0%	78	$0.00
82553		0%	16	$0.00
64494		0%	101	$0.00
82077		0%	302	$0.00
95012		0%	77	$0.00
J2790	Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)	0%	165	$0.00
A9270	Non-covered item or service	0%	504	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	13	$0.00
00813		0%	12	$0.00
82435		0%	17	$0.00
91319		0%	34	$0.00
82533		0%	49	$0.00
A4648	Tissue marker, implantable, any type, each	0%	192	$0.00
99417	Prolong home eval add 15m	0%	28	$0.00
88311		0%	53	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	30	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	54	$0.00
99459		0%	67	$0.00
91317		0%	24	$0.00
12002		0%	12	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	31	$0.00
86301		0%	34	$0.00
82103		0%	13	$0.00
C1778	Lead, neurostimulator (implantable)	0%	13	$0.00
77417		0%	54	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	240	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	70	$0.00
90381		0%	16	$0.00
0154A		0%	15	$0.00
82360		0%	37	$0.00
17250		0%	16	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	13	$0.00
91307		0%	55	$0.00
90636		0%	12	$0.00
C1781	Mesh (implantable)	0%	12	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	3,026	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	4,809	$0.00
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	0%	764	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	1,157	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	3,673	$0.00
90707		0%	1,394	$0.00
90472	Immunization administration, each additional vaccine (list separately)	0%	13,368	$0.00
90648		0%	1,894	$0.00
90633		0%	2,233	$0.00
90700		0%	1,145	$0.00
76942		0%	1,297	$0.00
J7030	Infusion, normal saline solution , 1000 cc	0%	5,517	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	565	$0.00
91300		0%	8,280	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	467	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	245	$0.00
88312		0%	30	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	371	$0.00
J1071	Injection, testosterone cypionate, 1 mg	0%	844	$0.00
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	0%	222	$0.00
88313		0%	295	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	181	$0.00
91312		0%	522	$0.00
76937		0%	13	$0.00
91308		0%	175	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	30	$0.00
C1788	Port, indwelling (implantable)	0%	195	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	97	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	766	$0.00
78434		0%	28	$0.00
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	0%	53	$0.00
93356		0%	128	$0.00
90671		0%	46	$0.00
C1729	Catheter, drainage	0%	263	$0.00
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	0%	47	$0.00
94727		0%	84	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	1,216	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	171	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	108	$0.00
J9263	Injection, oxaliplatin, 0.5 mg	0%	204	$0.00
91311		0%	59	$0.00
C1874	Stent, coated/covered, with delivery system	0%	43	$0.00
69220		0%	12	$0.00
J9060	Injection, cisplatin, powder or solution, 10 mg	0%	48	$0.00
85613		0%	13	$0.00
J9206	Injection, irinotecan, 20 mg	0%	110	$0.00
J9370	Vincristine sulfate, 1 mg	0%	32	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	44	$0.00
93321		0%	13	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	29	$0.00
91321		0%	68	$0.00
80179		0%	29	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	35	$0.00
80143		0%	18	$0.00
86146		0%	27	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	13	$0.00
86147		0%	26	$0.00
89050		0%	36	$0.00
76813		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialEDELMAN, MARC (SR. VP OF OPERATIONS)